Tendonitis Treatment Market Size, Share, And Trends Analysis Report By Treatment (Therapy, Surgery), By Condition (Tennis Elbow, Golfer’s Elbow), By Region (Asia Pacific, North America), And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Tendonitis Treatment Market Growth & Trends
The global tendonitis treatment market size is expected to reach USD 281.8 billion by 2030, registering a CAGR of 3.7% over the forecast period, according to a new report by Grand View Research, Inc. Growing participation in physical and sporting activities, directly influences the rise in prevalence of sports-related injuries. In addition, the rising incidence of occupational injuries is anticipated to contribute to the development and growth of the industry over the forecast period. The growing global geriatric population is susceptible to bone disorders, diabetes, arthritis, osteoarthritis, osteoporosis, or tendonitis. Industry participants that are constantly innovating advanced therapies and technologies in managing tendonitis are also contributing to the market growth.
Growing investments, industry collaborations, and increasing favorable government support are other key factors accelerating market growth. Over the past years, there has been a transition from proactive to preventive therapies in managing the health of sportspersons in preventing injuries. According to Standard Children’s Health, in 2018, approximately 3.5 million out of 30 million adolescents participating in sporting activities in the U.S. incur sports-related injuries. As per studies, annually, around 775,000 adolescents receive therapies and treatments for sports-related injuries in the U.S. Major players are expanding their business footprint in both developed and emerging economies through product innovation and strengthening their distribution cycles.
During the COVID-19 pandemic and enforced lockdowns and travel restrictions imposed across countries, the industry growth was negatively impacted owing to a decline in the number of tendonitis treatment procedures. Postponement and cancellation of sporting events led to a decline in the incidence of sports-related injuries, thereby, resulting in a decline in the business performance of the market. In 2021, the therapy segment accounted for the largest share and is anticipated to grow significantly over the forecast period. This is owing to the high preference for non-invasive treatment procedures. The first line of treatment management is physical therapy, which is expected to witness considerable growth.
The Achilles tendonitis segment dominated the industry in 2021. This growth can be attributed to the growing incidence of sports-related injuries in sports players. As per studies, the incidence rate of Achilles tendonitis ranges between 5 to 10 individuals per 100,000 people. North America accounted for the largest share in 2021 owing to the presence of renowned manufacturers and distributors, growing incidence of sports-related & trauma injuries, and rising awareness about the availability of various therapies & surgical procedures.
Tendonitis Treatment Market Report Highlights
Tendonitis Treatment Market Growth & Trends
The global tendonitis treatment market size is expected to reach USD 281.8 billion by 2030, registering a CAGR of 3.7% over the forecast period, according to a new report by Grand View Research, Inc. Growing participation in physical and sporting activities, directly influences the rise in prevalence of sports-related injuries. In addition, the rising incidence of occupational injuries is anticipated to contribute to the development and growth of the industry over the forecast period. The growing global geriatric population is susceptible to bone disorders, diabetes, arthritis, osteoarthritis, osteoporosis, or tendonitis. Industry participants that are constantly innovating advanced therapies and technologies in managing tendonitis are also contributing to the market growth.
Growing investments, industry collaborations, and increasing favorable government support are other key factors accelerating market growth. Over the past years, there has been a transition from proactive to preventive therapies in managing the health of sportspersons in preventing injuries. According to Standard Children’s Health, in 2018, approximately 3.5 million out of 30 million adolescents participating in sporting activities in the U.S. incur sports-related injuries. As per studies, annually, around 775,000 adolescents receive therapies and treatments for sports-related injuries in the U.S. Major players are expanding their business footprint in both developed and emerging economies through product innovation and strengthening their distribution cycles.
During the COVID-19 pandemic and enforced lockdowns and travel restrictions imposed across countries, the industry growth was negatively impacted owing to a decline in the number of tendonitis treatment procedures. Postponement and cancellation of sporting events led to a decline in the incidence of sports-related injuries, thereby, resulting in a decline in the business performance of the market. In 2021, the therapy segment accounted for the largest share and is anticipated to grow significantly over the forecast period. This is owing to the high preference for non-invasive treatment procedures. The first line of treatment management is physical therapy, which is expected to witness considerable growth.
The Achilles tendonitis segment dominated the industry in 2021. This growth can be attributed to the growing incidence of sports-related injuries in sports players. As per studies, the incidence rate of Achilles tendonitis ranges between 5 to 10 individuals per 100,000 people. North America accounted for the largest share in 2021 owing to the presence of renowned manufacturers and distributors, growing incidence of sports-related & trauma injuries, and rising awareness about the availability of various therapies & surgical procedures.
Tendonitis Treatment Market Report Highlights
- The industry is expected to have significant growth over the forecast period owing to the increasing participation in physical & sporting events, leading to a growth in the number of injuries, thereby requiring therapies and surgeries
- The emergence of innovative and advanced solutions is responsible for industry growth over the forecast period
- In 2021, the therapy treatment segment accounted for the largest revenue share owing to the increased preference for non-invasive treatment over the surgical procedure for tendonitis
- Based on the condition type, Achilles tendonitis held the largest revenue share in 2021 owing to the increased incidence of sports injuries
- North America was the largest region in 2021 on account of the high number of surgeries performed in the region
CHAPTER 1 RESEARCH METHODOLOGY & SCOPE
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 List of Secondary Sources
1.5 List of Primary Sources
1.6 Information or Data Analysis
1.6.1 Data Analysis Models
1.7 Market Formulation & Validation
1.7.1 Approach 1: Commodity Flow Approach
1.7.2 Global Market: CAGR Calculation
1.8 Abbreviations
1.9 Report Objectives
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.1.1 Tendonitis Treatment Market Estimates and Forecasts, 2016 - 2030 (USD Million)
2.2 Segment Outlook
2.3 Competitive Outlook
2.4 Tendonitis Market Summary, 2021
CHAPTER 3 TENDONITIS TREATMENT MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market analysis
3.1.2 Ancillary market Analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Pricing Analysis
3.4 Product Pipeline Analysis
3.5 Industry Analysis
3.5.1 Consumer behavior analysis
3.5.2 Market influencer analysis
3.5.2.1 North America
3.5.2.2 Europe
3.5.2.3 Asia Pacific
3.5.2.4 Latin America
3.5.2.5 MEA
3.5.3 List of key end-users, by product
3.6 Regulatory Framework
3.6.1 Reimbursement framework
3.6.2 Standards & compliance
3.6.2.1 CPT Coding implications
3.6.2.2 HCPCS Coding implications
3.6.3 Safety
3.7 Tendonitis Treatment Market Dynamics
3.7.1 Market driver analysis
3.7.1.1 Increasing prevalence of sports injuries
3.7.1.2 Technological advancements pertaining to novel product development
3.7.1.3 Growing awareness of tendonitis treatment options
3.7.2 Market restraint analysis
3.7.2.1 Insurance coverage is limited in emerging countries
3.8 Tendonitis Treatment Market Analysis Tools
3.8.1 Industry Analysis - Porters
3.8.1.1 Supplier Power- Moderately High
3.8.1.2 Buyer Power- Moderate
3.8.1.3 Threat Of Substitutes- Moderate
3.8.1.4 Threat Of New Entrants- Low
3.8.1.5 Competitive Rivalary- High
3.9.2 PESTEL Analysis
3.9.2.1 Political Landscape
3.9.2.2 Economic Landscape
3.9.2.3 Social Landscape
3.9.2.4 Technology Landscape
3.9.2.5 Environmental Landscape
3.9.2.6 Legal landscape
3.10. Major Deals & Strategic Alliances Analysis
CHAPTER 4 TENDONITIS TREATMENT MARKET: COMPETITIVE ANALYSIS
4.1 Market Participation Categorization
4.1.1 Regional network map
4.1.2 Innovators
4.1.3 Key company market share analysis, 2021
4.1.4 Company market share by region, 2021
4.2 Public Companies
4.2.1 Company market position analysis
4.2.2 Heat Map Analysis
4.3 Private Companies
4.3.1 List of emerging companies
4.3.2 Heat Map analysis
4.4 Vendor Landscape
4.4.1 List of key distributors and channel partners
4.4.2 Key customers
CHAPTER 5 TENDONITIS TREATMENT MARKET: TREATMENT ESTIMATES & TREND ANALYSIS
5.1 Treatment Market Share Analysis, 2021 & 2030
5.2 Treatment Dashboard
5.2.1 Therapy
5.2.1.1 Therapy Market Estimates And Forecasts, 2016 - 2030 (USD MILLION)
5.2.1.1.1 Hot and Cold Therapy
5.2.1.1.2 Physical Therapy
5.2.1.1.3 Shockwave Therapy
5.2.2 Surgery
5.2.2.1 Surgery Market Estimates And Forecasts, 2016 - 2030 (USD MILLION)
CHAPTER 6 TENDONITIS TREATMENT MARKET: CONDITION ESTIMATES & TREND ANALYSIS
6.1 Condition Market Share Analysis, 2021 & 2030
6.2 Condition Dashboard
6.2.1 Tennis Elbow
6.2.1.1 Tennis Elbow market estimates and forecasts, 2016 - 2030 (USD Million)
6.2.2 Golfer's Elbow
6.2.2.1 Golfer's Elbow market estimates and forecasts, 2016 - 2030 (USD Million)
6.2.3 Pitcher's Elbow
6.2.3.1 Pitcher's Elbow market estimates and forecasts, 2016 - 2030 (USD Million)
6.2.4 Jumper's Knee
6.2.4.1 Jumper's Knee market estimates and forecasts, 2016 - 2030 (USD Million)
6.2.5 Swimmer's Shoulder
6.2.5.1 Swimmer's Shoulder market estimates and forecasts, 2016 - 2030 (USD Million)
6.2.6 Achilles Tendonitis
6.2.6.1 Achilles Tendonitis market estimates and forecasts, 2016 - 2030 (USD Million)
CHAPTER 9 TENDONITIS TREATMENT MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY TREATMENT, BY CONDITION
9.1 Regional Dashboard
9.2 Regional Market Snapshot
9.3 Global tendonitis treatment market: Regional Movement Analysis
9.4 Market Share Analysis by Country, 2021
9.4.1 North America
9.4.2 Europe
9.4.3 Asia Pacific
9.4.4 Latin America
9.4.5 MEA
9.5 North America
9.5.1 North America Tendonitis Treatment Market estimates and forecasts, 2016 - 2030 (USD Million)
9.5.2 U.S.
9.5.2.1 U.S. Tendonitis Treatment Market estimates and forecasts, 2016 - 2030 (USD Million)
9.5.3 Canada
9.5.3.1 Canada Tendonitis Treatment Market estimates and forecasts, 2016 - 2030 (USD Million)
9.6 Europe
9.6.1 Europe Tendonitis Treatment Market estimates and forecasts, 2016 - 2030 (USD Million)
9.6.2 U.K.
9.6.2.1 U.K. Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.6.3 Germany
9.6.3.1 Germany Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.6.4 France
9.6.4.1 France Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.6.5 Italy
9.6.5.1 Italy Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.6.6 Spain
9.6.6.1 Spain Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.6.7 Russia
9.6.7.1 Russia Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.7 Asia Pacific
9.7.1 Asia Pacific Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.7.2 Japan
9.7.2.1 Japan Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.7.3 China
9.7.3.1 China Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.7.4 India
9.7.4.1 India Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.7.5 South Korea
9.7.5.1 South Korea Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.7.6 Singapore
9.7.6.1 Singapore Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.7.7 Australia
9.7.7.1 Australia Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.8 Latin America
9.8.1 Latin America Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.8.2 Mexico
9.8.2.1 Mexico Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.8.3 Brazil
9.8.3.1 Brazil Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.8.4 Argentina
9.8.4.1 Argentina Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.9 MEA
9.9.1 MEA Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.9.2 South Africa
9.9.2.1 South Africa Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.9.3 Saudi Arabia
9.9.3.1 Saudi Arabia Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.9.4 UAE
9.9.4.1 UAE Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
CHAPTER 10 COMPANY PROFILES
10.1 Merck & Co. Inc
10.1.1 Company overview
10.1.2 Financial performance
10.1.3 Product benchmarking
10.1.4 Strategic initiatives
10.2 AstraZeneca
10.2.1 Company overview
10.2.2 Financial performance
10.2.3 Product benchmarking
10.2.4 Strategic initiatives
10.3 Boehringer Ingelheim Pharmaceuticals, Inc
10.3.1 Company overview
10.3.2 Financial performance
10.3.3 Product benchmarking
10.3.4 Strategic initiatives
10.4 Abbott
10.4.1 Company overview
10.4.2 Financial performance
10.4.3 Product benchmarking
10.4.4 Strategic initiatives
10.5 Pfizer
10.5.1 Company overview
10.5.2 Financial performance
10.5.3 Product benchmarking
10.5.4 Strategic initiatives
10.6 Bayer AG
10.6.1 Company overview
10.6.2 Financial performance
10.6.3 Product benchmarking
10.6.4 Strategic initiatives
10.7 GlaxoSmithKline, PLC
10.7.1 Company overview
10.7.2 Financial performance
10.7.3 Product benchmarking
10.7.4 Strategic initiatives
10.8 Almatica Pharma, Inc
10.8.1 Company overview
10.8.2 Financial performance
10.8.3 Product benchmarking
10.8.4 Strategic initiatives
10.9 Teva Pharmaceuticals Industries
10.9.1 Company overview
10.9.2 Financial performance
10.9.3 Product benchmarking
10.9.4 Strategic initiatives
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 List of Secondary Sources
1.5 List of Primary Sources
1.6 Information or Data Analysis
1.6.1 Data Analysis Models
1.7 Market Formulation & Validation
1.7.1 Approach 1: Commodity Flow Approach
1.7.2 Global Market: CAGR Calculation
1.8 Abbreviations
1.9 Report Objectives
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.1.1 Tendonitis Treatment Market Estimates and Forecasts, 2016 - 2030 (USD Million)
2.2 Segment Outlook
2.3 Competitive Outlook
2.4 Tendonitis Market Summary, 2021
CHAPTER 3 TENDONITIS TREATMENT MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market analysis
3.1.2 Ancillary market Analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Pricing Analysis
3.4 Product Pipeline Analysis
3.5 Industry Analysis
3.5.1 Consumer behavior analysis
3.5.2 Market influencer analysis
3.5.2.1 North America
3.5.2.2 Europe
3.5.2.3 Asia Pacific
3.5.2.4 Latin America
3.5.2.5 MEA
3.5.3 List of key end-users, by product
3.6 Regulatory Framework
3.6.1 Reimbursement framework
3.6.2 Standards & compliance
3.6.2.1 CPT Coding implications
3.6.2.2 HCPCS Coding implications
3.6.3 Safety
3.7 Tendonitis Treatment Market Dynamics
3.7.1 Market driver analysis
3.7.1.1 Increasing prevalence of sports injuries
3.7.1.2 Technological advancements pertaining to novel product development
3.7.1.3 Growing awareness of tendonitis treatment options
3.7.2 Market restraint analysis
3.7.2.1 Insurance coverage is limited in emerging countries
3.8 Tendonitis Treatment Market Analysis Tools
3.8.1 Industry Analysis - Porters
3.8.1.1 Supplier Power- Moderately High
3.8.1.2 Buyer Power- Moderate
3.8.1.3 Threat Of Substitutes- Moderate
3.8.1.4 Threat Of New Entrants- Low
3.8.1.5 Competitive Rivalary- High
3.9.2 PESTEL Analysis
3.9.2.1 Political Landscape
3.9.2.2 Economic Landscape
3.9.2.3 Social Landscape
3.9.2.4 Technology Landscape
3.9.2.5 Environmental Landscape
3.9.2.6 Legal landscape
3.10. Major Deals & Strategic Alliances Analysis
CHAPTER 4 TENDONITIS TREATMENT MARKET: COMPETITIVE ANALYSIS
4.1 Market Participation Categorization
4.1.1 Regional network map
4.1.2 Innovators
4.1.3 Key company market share analysis, 2021
4.1.4 Company market share by region, 2021
4.2 Public Companies
4.2.1 Company market position analysis
4.2.2 Heat Map Analysis
4.3 Private Companies
4.3.1 List of emerging companies
4.3.2 Heat Map analysis
4.4 Vendor Landscape
4.4.1 List of key distributors and channel partners
4.4.2 Key customers
CHAPTER 5 TENDONITIS TREATMENT MARKET: TREATMENT ESTIMATES & TREND ANALYSIS
5.1 Treatment Market Share Analysis, 2021 & 2030
5.2 Treatment Dashboard
5.2.1 Therapy
5.2.1.1 Therapy Market Estimates And Forecasts, 2016 - 2030 (USD MILLION)
5.2.1.1.1 Hot and Cold Therapy
5.2.1.1.2 Physical Therapy
5.2.1.1.3 Shockwave Therapy
5.2.2 Surgery
5.2.2.1 Surgery Market Estimates And Forecasts, 2016 - 2030 (USD MILLION)
CHAPTER 6 TENDONITIS TREATMENT MARKET: CONDITION ESTIMATES & TREND ANALYSIS
6.1 Condition Market Share Analysis, 2021 & 2030
6.2 Condition Dashboard
6.2.1 Tennis Elbow
6.2.1.1 Tennis Elbow market estimates and forecasts, 2016 - 2030 (USD Million)
6.2.2 Golfer's Elbow
6.2.2.1 Golfer's Elbow market estimates and forecasts, 2016 - 2030 (USD Million)
6.2.3 Pitcher's Elbow
6.2.3.1 Pitcher's Elbow market estimates and forecasts, 2016 - 2030 (USD Million)
6.2.4 Jumper's Knee
6.2.4.1 Jumper's Knee market estimates and forecasts, 2016 - 2030 (USD Million)
6.2.5 Swimmer's Shoulder
6.2.5.1 Swimmer's Shoulder market estimates and forecasts, 2016 - 2030 (USD Million)
6.2.6 Achilles Tendonitis
6.2.6.1 Achilles Tendonitis market estimates and forecasts, 2016 - 2030 (USD Million)
CHAPTER 9 TENDONITIS TREATMENT MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY TREATMENT, BY CONDITION
9.1 Regional Dashboard
9.2 Regional Market Snapshot
9.3 Global tendonitis treatment market: Regional Movement Analysis
9.4 Market Share Analysis by Country, 2021
9.4.1 North America
9.4.2 Europe
9.4.3 Asia Pacific
9.4.4 Latin America
9.4.5 MEA
9.5 North America
9.5.1 North America Tendonitis Treatment Market estimates and forecasts, 2016 - 2030 (USD Million)
9.5.2 U.S.
9.5.2.1 U.S. Tendonitis Treatment Market estimates and forecasts, 2016 - 2030 (USD Million)
9.5.3 Canada
9.5.3.1 Canada Tendonitis Treatment Market estimates and forecasts, 2016 - 2030 (USD Million)
9.6 Europe
9.6.1 Europe Tendonitis Treatment Market estimates and forecasts, 2016 - 2030 (USD Million)
9.6.2 U.K.
9.6.2.1 U.K. Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.6.3 Germany
9.6.3.1 Germany Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.6.4 France
9.6.4.1 France Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.6.5 Italy
9.6.5.1 Italy Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.6.6 Spain
9.6.6.1 Spain Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.6.7 Russia
9.6.7.1 Russia Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.7 Asia Pacific
9.7.1 Asia Pacific Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.7.2 Japan
9.7.2.1 Japan Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.7.3 China
9.7.3.1 China Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.7.4 India
9.7.4.1 India Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.7.5 South Korea
9.7.5.1 South Korea Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.7.6 Singapore
9.7.6.1 Singapore Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.7.7 Australia
9.7.7.1 Australia Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.8 Latin America
9.8.1 Latin America Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.8.2 Mexico
9.8.2.1 Mexico Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.8.3 Brazil
9.8.3.1 Brazil Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.8.4 Argentina
9.8.4.1 Argentina Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.9 MEA
9.9.1 MEA Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.9.2 South Africa
9.9.2.1 South Africa Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.9.3 Saudi Arabia
9.9.3.1 Saudi Arabia Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
9.9.4 UAE
9.9.4.1 UAE Tendonitis Treatment market estimates and forecasts, 2016 - 2030 (USD Million)
CHAPTER 10 COMPANY PROFILES
10.1 Merck & Co. Inc
10.1.1 Company overview
10.1.2 Financial performance
10.1.3 Product benchmarking
10.1.4 Strategic initiatives
10.2 AstraZeneca
10.2.1 Company overview
10.2.2 Financial performance
10.2.3 Product benchmarking
10.2.4 Strategic initiatives
10.3 Boehringer Ingelheim Pharmaceuticals, Inc
10.3.1 Company overview
10.3.2 Financial performance
10.3.3 Product benchmarking
10.3.4 Strategic initiatives
10.4 Abbott
10.4.1 Company overview
10.4.2 Financial performance
10.4.3 Product benchmarking
10.4.4 Strategic initiatives
10.5 Pfizer
10.5.1 Company overview
10.5.2 Financial performance
10.5.3 Product benchmarking
10.5.4 Strategic initiatives
10.6 Bayer AG
10.6.1 Company overview
10.6.2 Financial performance
10.6.3 Product benchmarking
10.6.4 Strategic initiatives
10.7 GlaxoSmithKline, PLC
10.7.1 Company overview
10.7.2 Financial performance
10.7.3 Product benchmarking
10.7.4 Strategic initiatives
10.8 Almatica Pharma, Inc
10.8.1 Company overview
10.8.2 Financial performance
10.8.3 Product benchmarking
10.8.4 Strategic initiatives
10.9 Teva Pharmaceuticals Industries
10.9.1 Company overview
10.9.2 Financial performance
10.9.3 Product benchmarking
10.9.4 Strategic initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Product pipeline/clinical stage
Table 4 CPT coding
Table 5 HCPCS coding
Table 6 ICD-10-CM coding
Table 7 List of emerging companies in tendonitis treatment market
Table 8 North America Tendonitis Treatment market, by country, 2016 - 2030 (USD Million)
Table 9 North America Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 10 North America Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 11 U.S. Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 12 U.S. Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 13 Canada Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 14 Canada Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 15 Europe Tendonitis Treatment market, by country, 2016 - 2030 (USD Million)
Table 16 Europe Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 17 Europe Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 18 U.K. Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 19 U.K. Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 20 Germany Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 21 Germany Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 22 France Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 23 France Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 24 Spain Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 25 Spain Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 26 Italy Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 27 Italy Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 28 Russia Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 29 Russia Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 30 Asia Pacific Tendonitis Treatment market, by country, 2016 - 2030 (USD Million)
Table 31 Asia Pacific Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 32 Asia Pacific Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 33 China Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 34 China Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 35 Japan Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 36 Japan Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 37 India Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 38 India Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 39 Singapore Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 40 Singapore Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 41 Australia Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 42 Australia Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 43 South Korea Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 44 South Korea Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 45 Latin America Tendonitis Treatment market, by country, 2016 - 2030 (USD Million)
Table 46 Latin America Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 47 Latin America Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million
Table 48 Brazil Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 49 Brazil Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 50 Mexico Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 51 Mexico Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 52 Argentina Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table53 Argentina Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 54 MEA Tendonitis Treatment market, by country, 2016 - 2030 (USD Million)
Table 55 MEA Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 56 MEA Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 57 South Africa Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 58 South Africa Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 59 Saudi Arabia Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 60 Saudi Arabia Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 61 UAE Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 62 UAE Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Product pipeline/clinical stage
Table 4 CPT coding
Table 5 HCPCS coding
Table 6 ICD-10-CM coding
Table 7 List of emerging companies in tendonitis treatment market
Table 8 North America Tendonitis Treatment market, by country, 2016 - 2030 (USD Million)
Table 9 North America Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 10 North America Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 11 U.S. Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 12 U.S. Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 13 Canada Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 14 Canada Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 15 Europe Tendonitis Treatment market, by country, 2016 - 2030 (USD Million)
Table 16 Europe Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 17 Europe Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 18 U.K. Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 19 U.K. Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 20 Germany Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 21 Germany Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 22 France Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 23 France Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 24 Spain Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 25 Spain Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 26 Italy Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 27 Italy Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 28 Russia Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 29 Russia Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 30 Asia Pacific Tendonitis Treatment market, by country, 2016 - 2030 (USD Million)
Table 31 Asia Pacific Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 32 Asia Pacific Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 33 China Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 34 China Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 35 Japan Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 36 Japan Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 37 India Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 38 India Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 39 Singapore Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 40 Singapore Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 41 Australia Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 42 Australia Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 43 South Korea Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 44 South Korea Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 45 Latin America Tendonitis Treatment market, by country, 2016 - 2030 (USD Million)
Table 46 Latin America Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 47 Latin America Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million
Table 48 Brazil Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 49 Brazil Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 50 Mexico Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 51 Mexico Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 52 Argentina Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table53 Argentina Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 54 MEA Tendonitis Treatment market, by country, 2016 - 2030 (USD Million)
Table 55 MEA Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 56 MEA Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 57 South Africa Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 58 South Africa Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 59 Saudi Arabia Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 60 Saudi Arabia Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
Table 61 UAE Tendonitis Treatment market, by treatment, 2016 - 2030 (USD Million)
Table 62 UAE Tendonitis Treatment market, by condition, 2016 - 2030 (USD Million)
LIST OF FIGURES
Figure 1. Market segmentation
Figure 2. Estimates and Forecast Timeline
Figure 3. market research process
Figure 4. Data triangulation techniques
Figure 5. PriFigure ary research pattern
Figure 6. Market research approaches
Figure 7. Value-chain-based sizing & forecasting
Figure 8. QFD Figure odeling for Market share assessFigure ent
Figure 9. Market for Figure ulation & validation
Figure 10. Tendonitis Treatment Market estiFigure ates and forecasts, 2016 - 2030 (USD Million)
Figure 11. SegFigure ent outlook, 2016 - 2030, USD Million
Figure 12. Strategy fraFigure ework outlook
Figure 13. Tendonitis Treatment Market snapshot, (2021, USD Million)
Figure 14. Penetration & growth prospect Figure apping
Figure 15. ConsuFigure er behavior analysis
Figure 16. North AFigure erica factors influencing tendonitis Treatment Market (%)
Figure 17. Europe factors influencing tendonitis Treatment Market (%)
Figure 18. Asia Pacific: factors influencing tendonitis Treatment Market (%)
Figure 19. Latin AFigure erica: factors influencing tendonitis Treatment Market (%)
Figure 20. Figure EA: factors influencing tendonitis Treatment Market (%)
Figure 21. Technology iFigure pact analysis
Figure 22. Tendonitis Treatment Market dynaFigure ics
Figure 23. Tendonitis Treatment Market driver iFigure pact
Figure 24. Tendonitis Treatment Market restraint iFigure pact
Figure 25. Market participant categorization
Figure 26. Regional network map
Figure 27. Tendonitis Treatment Market: Market leaders and innovators
Figure 28. CoFigure pany Market share analysis, 2021
Figure 29. CoFigure pany Market share by region, 2021
Figure 30. CoFigure pany Market position analysis
Figure 31. Tendonitis Treatment Market: Treatment movement analysis
Figure 32. Tendonitis Treatment Market Treatment dashboard
Figure 33. Tendonitis Treatment Market: Condition movement analysis
Figure 34. Tendonitis Treatment Market Condition dashboard
Figure 35. Regional dashboard
Figure 36. Regional Marketplace: Key takeaways
Figure 37. Regional outlook, 2021 & 2030
Figure 38. North AFigure erica Tendonitis Treatment Market share by countries, 2021
Figure 39. Europe Tendonitis Treatment Market share by countries, 2021
Figure 40. Asia Pacific Tendonitis Treatment Market share by countries, 2021
Figure 41. Latin AFigure erica Tendonitis Treatment Market share by countries, 2021
Figure 42. MEA Tendonitis Treatment Market share by countries, 2021
Figure 43. North AFigure erica Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 44. U.S. Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 45. Canada Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 46. Europe Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 47. U.K. Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 48. Germany Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 49. France Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 50. Italy Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 51. Spain Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 52. Russia Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 53. Asia Pacific Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 54. Japan Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 55. China Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 56. India Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 57. South Korea Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 58. Singapore Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 59. Australia Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 60. Latin AFigure erica Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 61. Mexico Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 62. Brazil Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 63. Argentina Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 64. MEA Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 65. South Africa Tendonitis Treatment Market , 2016 - 2030 (USD Million)
Figure 66. Saudi Arabia Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 67. UAE Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 1. Market segmentation
Figure 2. Estimates and Forecast Timeline
Figure 3. market research process
Figure 4. Data triangulation techniques
Figure 5. PriFigure ary research pattern
Figure 6. Market research approaches
Figure 7. Value-chain-based sizing & forecasting
Figure 8. QFD Figure odeling for Market share assessFigure ent
Figure 9. Market for Figure ulation & validation
Figure 10. Tendonitis Treatment Market estiFigure ates and forecasts, 2016 - 2030 (USD Million)
Figure 11. SegFigure ent outlook, 2016 - 2030, USD Million
Figure 12. Strategy fraFigure ework outlook
Figure 13. Tendonitis Treatment Market snapshot, (2021, USD Million)
Figure 14. Penetration & growth prospect Figure apping
Figure 15. ConsuFigure er behavior analysis
Figure 16. North AFigure erica factors influencing tendonitis Treatment Market (%)
Figure 17. Europe factors influencing tendonitis Treatment Market (%)
Figure 18. Asia Pacific: factors influencing tendonitis Treatment Market (%)
Figure 19. Latin AFigure erica: factors influencing tendonitis Treatment Market (%)
Figure 20. Figure EA: factors influencing tendonitis Treatment Market (%)
Figure 21. Technology iFigure pact analysis
Figure 22. Tendonitis Treatment Market dynaFigure ics
Figure 23. Tendonitis Treatment Market driver iFigure pact
Figure 24. Tendonitis Treatment Market restraint iFigure pact
Figure 25. Market participant categorization
Figure 26. Regional network map
Figure 27. Tendonitis Treatment Market: Market leaders and innovators
Figure 28. CoFigure pany Market share analysis, 2021
Figure 29. CoFigure pany Market share by region, 2021
Figure 30. CoFigure pany Market position analysis
Figure 31. Tendonitis Treatment Market: Treatment movement analysis
Figure 32. Tendonitis Treatment Market Treatment dashboard
Figure 33. Tendonitis Treatment Market: Condition movement analysis
Figure 34. Tendonitis Treatment Market Condition dashboard
Figure 35. Regional dashboard
Figure 36. Regional Marketplace: Key takeaways
Figure 37. Regional outlook, 2021 & 2030
Figure 38. North AFigure erica Tendonitis Treatment Market share by countries, 2021
Figure 39. Europe Tendonitis Treatment Market share by countries, 2021
Figure 40. Asia Pacific Tendonitis Treatment Market share by countries, 2021
Figure 41. Latin AFigure erica Tendonitis Treatment Market share by countries, 2021
Figure 42. MEA Tendonitis Treatment Market share by countries, 2021
Figure 43. North AFigure erica Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 44. U.S. Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 45. Canada Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 46. Europe Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 47. U.K. Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 48. Germany Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 49. France Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 50. Italy Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 51. Spain Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 52. Russia Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 53. Asia Pacific Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 54. Japan Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 55. China Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 56. India Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 57. South Korea Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 58. Singapore Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 59. Australia Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 60. Latin AFigure erica Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 61. Mexico Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 62. Brazil Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 63. Argentina Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 64. MEA Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 65. South Africa Tendonitis Treatment Market , 2016 - 2030 (USD Million)
Figure 66. Saudi Arabia Tendonitis Treatment Market, 2016 - 2030 (USD Million)
Figure 67. UAE Tendonitis Treatment Market, 2016 - 2030 (USD Million)
